Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | GEN1055 |
| Synonyms | |
| Therapy Description |
GEN1055 is an agonist antibody targeting TNFRSF4 (OX40, CD134), which potentially induces proliferation of CD4+ and CD8+ T lymphocytes and enhances antitumor immune response (Immuno-Oncology and Technology 20 (2023)). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| GEN1055 | GEN-1055|GEN 1055|HexaBody-OX40|BNT315 | OX40 Antibody 15 | GEN1055 is an agonist antibody targeting TNFRSF4 (OX40, CD134), which potentially induces proliferation of CD4+ and CD8+ T lymphocytes and enhances antitumor immune response (Immuno-Oncology and Technology 20 (2023)). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|